GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
about
Paroxetine versus other anti-depressive agents for depressionCitalopram versus other anti-depressive agents for depressionGenetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysisAdverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individualsAllowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.Involving patients with depression in research: survey of patients' attitudes to participation.The acute side effects of bright light therapy: a placebo-controlled investigation.Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial.Psychological advocacy toward healing (PATH): study protocol for a randomized controlled trial.Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.Copy number variants and therapeutic response to antidepressant medication in major depressive disorder.Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
P2860
Q24197507-050E966A-E997-4CCC-97E8-05F2E794D777Q24202141-8632D93A-A04B-4676-936C-F5A17B662660Q28484419-B691C98F-5D05-4AA1-A944-DEC93C00BBF5Q33906501-4BBD08C7-4AAE-454E-85B5-B1D1F368DD5CQ34038812-D229FB6F-31B9-4D4A-A342-86C8BB8A9502Q34711882-FE7C12BC-656B-483D-83BB-F16938513D45Q35006066-D5701C27-33F4-4AEC-B533-4CDD151C986DQ35044690-C71C67C1-2B9B-4D64-AD52-330BA2ECB143Q37033257-A3C11915-FA6C-49AF-9DEB-28BA103FCE37Q38154916-D7EE3D78-1AAD-4B9E-90C2-72AF36D16680Q42361493-F14C4C9A-07B0-4C3C-8FF7-375AD1D2CA9AQ47436767-DAA39F7C-6C2A-415D-BAB1-E51C5BF8A829Q48367416-30951F7E-660E-4F15-B577-E01127EF3514Q48372657-16BDE057-82DD-46F5-813D-92A765A19F75Q48765199-E2A978B1-801B-401C-91F8-4B089E7DB801
P2860
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
GENetic and clinical predictor ...... Pod randomised trial protocol.
@ast
GENetic and clinical predictor ...... Pod randomised trial protocol.
@en
type
label
GENetic and clinical predictor ...... Pod randomised trial protocol.
@ast
GENetic and clinical predictor ...... Pod randomised trial protocol.
@en
prefLabel
GENetic and clinical predictor ...... Pod randomised trial protocol.
@ast
GENetic and clinical predictor ...... Pod randomised trial protocol.
@en
P2093
P2860
P50
P356
P1433
P1476
GENetic and clinical predictor ...... Pod randomised trial protocol.
@en
P2093
Debbie Tallon
Jean Mulligan
Laura Thomas
Victoria Mason
P2860
P2888
P356
10.1186/1745-6215-9-29
P577
2008-05-22T00:00:00Z
P5875
P6179
1017837692